Our results underscore the novel role of lncXIST in promoting M2-like macrophage polarization via the miR-17-5a/PDGFRA axis as well as its potential as both a diagnostic biomarker and a therapeutic target for colon cancer. Here, PDGFRA is linked to malignant colon neoplasm.